Background: It has been suggested that certain medical conditions and drug exposures might suppress the immune system and increase the risk of developing non-Hodgkin's lymphoma (NHL). Purpose: We investigated whether specific medical conditions and drug exposures were associated with the risk of NHL in a cohort of older women who were enrolled in the Iowa Women's Health Study. Methods: A cohort of 41 837 women, 55-69 years of age at baseline, was followed prospectively for the development of cancer from 1986 through 1992. These women had completed a baseline questionnaire in January 1986 that inquired about the occurrence and age at onset of specific medical conditions, about family history of cancer, and about the use of selected medications. Follow-up questionnaires were mailed to the women in 1987, 1989, and 1992. Incident cancers and deaths were ascertained through linkages to state and national databases. For most analyses, women with a self-reported history of cancer at baseline (n = 3903) were excluded. Relative risks (RRs) and 95% confidence intervals (CIs), adjusted for age or for age and other variables, were used as a measure of the association between NHL and medical history factors. Reported P values are two-sided. Results: One hundred fourteen incident cases of NHL were identified in the cohort during follow-up. A history of adult-onset diabetes mellitus (i.e., first diagnosed after the age of 30 years) was associated with an increased risk of developing NHL (age-adjusted RR = 2.18; 95% CI = 1.22-3.90). In addition, there was an association between the duration of adult-onset diabetes and increasing risk of NHL (P for trend =
.004), with an age-adjusted RR of 2.90 (95% CI = 1.07-7.90) for women with a diagnosis of diabetes for 15 or more years compared with women with no diagnosis of diabetes. Women with a history of blood transfusion were also at increased risk for the development of NHL (age-adjusted RR = 1.95; 95% CI = 1.33-2.85). The risk estimates for diabetes and transfusion history were independent of each other and were not changed substantially after adjustment for other risk factors. History of a previous cancer (excluding hematopoietic and lymphatic cancers) was associated with an increased risk of NHL (ageadjusted RR = 1.92; 95% CI = 1.21-3.06); this risk estimate was attenuated somewhat after adjustment for a history of diabetes, transfusion history, and other major risk factors (RR = 1.66; 95% CI = 1.02-2.69). No statistically significant associations were found between NHL and a history of chronic colitis, nonestrogen steroid use, use of exogenous estrogens, or use of thyroid medications. Conclusions and Implications: A history of adult-onset diabetes mellitus, blood transfusion, and a history of cancer (or its treatment) appear to be independent risk factors for NHL in older women. [J Natl Cancer Inst 1997;89:314-8]
The incidence of non-Hodgkin's lymphoma (NHL) in the United States increased approximately 73% from 1973 through 1991, a percentage increase that was exceeded only by the increases in prostate cancer, lung cancer in women, and melanoma. This increase is part of a longer trend documented since 1950 (1) , and improved medical technology and changing systems of diagnostic classification can explain only part of it (2) . The strongest known risk factors for NHL are immune-suppressed states caused by primary immune deficiency diseases (3) or acquired immune alterations (e.g., iatrogenic suppression, Sjøgren's syndrome, and human immunodeficiency virus infection) (4) ; the risk of developing NHL among patients in immune-suppressed states is 10 to several hundred times greater than that of the general population. However, these immunocompromised states are relatively rare and cannot explain the long-term and large increase in NHL incidence, particularly among the elderly (5).
We previously reported (6) a twofold increased risk of NHL associated with a self-reported history of blood transfusion in a cohort of older women enrolled in the Iowa Women's Health Study, even for a transfusion occurring more than 30 years before baseline. We hypothesized that this association was a consequence of the immunosuppressive effects of homologous blood and that the lower relative risks (RRs) (compared with the risks for individuals in severe immunodeficiency states) were probably due to a weaker, but biologically important, level of immune suppression. Other researchers have also hypothesized that certain medical conditions and drug exposures (e.g., diabetes mellitus, history of allergy or hives, previous use of nonestrogen steroids, chronic colitis, use of thyroid supplements, and use of exogenous estrogens) might alter immunocompetence and therefore influence NHL risk (4, 5) . We therefore investigated whether some of these medical history factors are associated with the risk of NHL in the same large cohort of older women.
Methods
The Iowa Women's Health Study was reviewed and approved by the institutional review boards of the University of Iowa and the University of Minnesota. In January 1986, a mailed questionnaire was completed by 41 837 (43% of total) randomly selected women who were 55-69 years of age and had a valid Iowa driver's license in 1985 (7) . There were only minor demographic differences between the re-spondents and the nonrespondents at baseline (8) , but the respondents have shown somewhat lower 5-year cancer incidence and mortality rates, mainly for diseases related to smoking (9) .
The baseline questionnaire inquired about the occurrence and age at onset of selected medical conditions previously diagnosed by a physician, any history of cancer in a first-or second-degree female relative, and use of selected medications. All data were self-reported, although a previous validation study for this cohort found that a self-reported diagnosis of cancer compared well with physician report (8) .
Vital status and cancer incidence were ascertained through 7 years of follow-up (1986 through 1992). Follow-up questionnaires were mailed in 1987, 1989 , and 1992 to assess vital status and address changes. Deaths were ascertained by linkage to Iowa death-certificate data and, for nonresponders and emigrants from Iowa, to the National Death Index. Approximately 4% of the cohort has been censored for migration out of Iowa. Vital status is estimated to be unknown for less than 1% of the cohort.
Incident cancers, except for nonmelanoma skin cancers, were ascertained through annual linkages of the cohort to the State Health Registry of Iowa cancer database, which is part of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) 1 Program (1). The 41 837 participants were linked annually to the database by use of combinations of first, last, and maiden names; ZIP Code; birthdate; and Social Security number.
For most analyses, women with a self-reported history of cancer at the baseline survey (1986) were excluded (n ‫ס‬ 3903) to provide a cancer-free cohort at risk. For analyses involving previous cancer as a risk factor for the development of NHL, only women with a history of hematopoietic or lymphatic cancer at baseline were excluded (n ‫ס‬ 145). Person-years of follow-up for each woman were accumulated from the date of the 1986 baseline questionnaire to the date of NHL diagnosis, emigration from Iowa, or death; if none of these events occurred, follow-up was through December 1992. Incidence rates were calculated by dividing the number of events by the number of person-years of follow-up for the categories of interest. RRs and 95% confidence intervals (CIs) were used as the measure of association; the Mantel-Haenszel procedure (10) was used for ageadjusted results, and Cox proportional hazards regression (11) was used for multivariate modeling. Farm residence (12) , marital status, diet (high consumption of red meat and low consumption of fruits) (13), history of cancer in female relatives, obesity, and body fat distribution were all evaluated as potential confounders. The assumption of proportional hazards for the main exposures of interest was tested and found not to be violated. Analyses were conducted using SAS statistical software (SAS Institute, Inc., Cary, NC). Reported P values are two-sided.
Results
There were 37 934 women (mean age, 61.5 years) who reported no history of cancer at baseline in 1986. During 251 489 person-years of follow-up (through 1992), there were 114 incident cases of NHL. A baseline history of chronic colitis was not associated with NHL risk, but a history of diabetes mellitus was a risk factor (Table 1) . Women with an onset of diabetes at or before age 30 years (the vast majority of women in this group would be expected to have juvenile-onset or type I diabetes) had an increased risk of NHL (RR ‫ס‬ 4.13; 95% CI ‫ס‬ 0.58-29.6), although the study power was low to detect such an association. Women with an onset of diabetes after age 30 years (the vast majority of women in this group would be expected to have adult-onset or type II diabetes) also had an increased risk of NHL (RR ‫ס‬ However, evaluation of the independent effect of therapy for diabetes was not possible because these data are sparse and highly confounded by the duration of disease. Consistent with our previous report based on an analysis of 5-year data (6), ever having had a blood transfusion was associated with an increased risk of NHL (RR ‫ס‬ 1.95; 95% CI ‫ס‬ 1.33-2.85). This risk was highest for the occurrence of a first transfusion during the 5-year interval before baseline, but it remained elevated even for those whose first transfusion occurred more than 30 years before baseline.
To determine whether a history of cancer was a risk factor for NHL, we included in the analysis women with baseline cancers other than lymphatic or hematopoietic cancers (total, 274 939 person-years and 135 NHL cases). Women reporting a previous cancer were at an increased risk of NHL (RR ‫ס‬ 1.92; 95% CI ‫ס‬ 1.21-3.06). While there was limited power to detect site-specific associations, the RRs were strongest for women reporting a previous colon cancer or a previous breast cancer.
Previous use of nonestrogen steroids was associated with an increased risk of NHL that was not statistically significant (RR ‫ס‬ 1.65; 95% CI ‫ס‬ 0.86-3.17). Previous use of exogenous estrogen agents (oral contraceptives or hormonereplacement therapy) or medications for thyroid dysfunction were not associated with the risk of NHL.
A history of blood transfusion and adult-onset diabetes mellitus remained statistically significant predictors of NHL in a multivariate model that adjusted for age, marital status, and residence (farm versus nonfarm) (Table 2, model I). There was no evidence of a first-order interaction between a history of blood transfusion and adult-onset diabetes (P ‫ס‬ .8). Adult-onset diabetes was also independent of body mass index and body fat distribution (as measured by waist-to-hip ratio), which were not themselves risk factors for NHL in this study (data not shown). There was also no appreciable change in the risk estimates when red meat and fruit consumption were added to model I (data not shown). The elevated RR estimate for previous use of nonestrogen steroids in the age-adjusted analyses (Table 1) was attenuated (RR ‫ס‬ 1.26; 95% CI ‫ס‬ 0.61-2.60) after adjusting for these other factors (mainly from inclusion of transfusion history in model I). A history of cancer remained a significant independent predictor of NHL in a multivariate model that included age, marital status, residence, transfusion history, and history of adult-onset diabetes (Table 2 , model II).
The associations observed for transfusion history, history of adult-onset diabetes, and history of a previous cancer could potentially be explained by a detection bias; that is, women with these conditions (particularly the latter two) are likely to be under closer medical surveillance and, thus, might merely be diagnosed earlier with NHL. To partially address this potential bias, we refitted the models in Table 2 using 1) localized NHL at diagnosis as the outcome and 2) disseminated NHL at diagnosis as the outcome. The rationale for this stratification was that, if such a bias explained our findings, then the associations should be stronger for localized disease than for disseminated disease at diagnosis. The association of adult-onset diabetes with localized NHL was 1.35 (95% CI ‫ס‬ 0.49-3.77) compared with 2.86 (95% CI ‫ס‬ 1.34-6.10) for disseminated disease; the associations for transfusion history were 1.77 (95% CI ‫ס‬ 0.98-3.19) and 2.34 (95% CI ‫ס‬ 1.34-4.09), respectively, and, for history of a previous cancer, they were 1.81 (95% CI ‫ס‬ 0.89-3.69) and 1.98 (95% CI ‫ס‬ 1.01-3.89), respectively. Thus, for all three predictors, the RRs were stronger when the outcome was disseminated NHL.
Discussion
To our knowledge, this is the first prospective cohort study using an internal comparison group to show that women with a self-reported history of adult-onset diabetes have an increased risk of developing NHL. Detection bias did not appear to explain the results, since the associations held irrespective of stage at diagnosis and there was a clear dose-response relationship between NHL risk and the amount of time since the diagnosis of diabetes.
Diabetes has been most consistently associated with cancers of the pancreas, the endometrium and, more recently, the liver (14) (15) (16) (17) . Three studies have compared cancer rates in cohorts of patients with diabetes with the general population: two (15, 18) found an elevated risk for NHL, while a third (17) found no association with the risk of developing hema- (19) . Among six case-control studies that have assessed this association, two have reported a positive association (16, 20) , three have reported no association (21, 22) , and one has reported an inverse association (23) . Another approach to assessing this association has been to compare post-load plasma glucose (i.e., the plasma glucose level measured after an oral glucose challenge) as a risk factor for NHL. Persons dying of a hematologic or lymphatic cancer in the Chicago Heart Association Detection Program were reported to have a higher baseline post-load plasma glucose level than the remainder of the cohort (147.7 versus 140.7 mg/dL, respectively); however, no statistical analysis was reported (24) . This observation could not be replicated in another study with a similar design (25) .
We have no laboratory data to define accurately the type and severity of diabetes, and we have had to rely on selfreport. Approximately 50% of all older white female diabetics are undiagnosed (26); however, a positive self-report of this condition is generally quite accurate in epidemiologic studies (27) . Before diagnosis, adult-onset diabetes is preceded by a long period of insulin resistance, a compensatory hyperinsulinemia, abnormal carbohydrate and lipid metabolism, and other metabolic alterations (28) . Diabetic patients have an increased susceptibility to infections, and hypothesized mechanisms include impaired neutrophil activity, alterations in serum immunoglobulins, and suppression of the cellular immune system (29) . Insulin stimulates cell growth, either directly through the insulin receptor or through its ability to cross-react with the insulin-like growth factor I receptor, and it is generally held that growth factors are likely to play an important role in carcinogenesis (30) . However, it is not known if insulin directly stimulates the growth of lymphomas in humans.
Treatment of diabetes, rather than the disease itself, could also be of etiologic importance. Adverse reactions to sulfonylureas include agranulocytosis, aplastic anemia, bone marrow aplasia, and hemolytic anemia, but these clinically apparent conditions are relatively rare (31) , and tumor-inducing effects have not been reported. Various types of insulins are also known to be immunogenic (32) . In our data, women who previously took oral agents or both oral agents and insulin had an increased risk of NHL compared with women without diabetes; however, potential treatment effects were confounded by duration of the disease, and no conclusion about the role of treatment was possible. Finally, the association between diabetes and NHL could be a consequence of shared genetic, infectious, or environmental etiologic factors.
With the use of 5-year data from this cohort, we previously reported that a history of blood transfusion is a risk factor for NHL (6) ; this association persisted in the 7-year data presented here. This finding is consistent with the data from two other cohort studies (33, 34) and one casecontrol study (35) . The limited data accumulated to date suggest that the association is unlikely to be confounded by the indication for transfusion or the presence of subclinical NHL. Blood transfusion is known to suppress the immune system (36) , and this suppression has been suggested as a potential mechanism for the transfusion-NHL association (6, 33) . Viral transmission or an interaction between transfusion-induced immunomodulation and viral transmission may also explain this association.
Our finding that a history of cancer is associated with increased risk of NHL confirms at least two reports from casecontrol studies (20, 21) . While our data suggest that a previous colon or breast cancer in particular increased the risk of NHL, small numbers and the fact that the "all other cancers" category also showed an increase in risk (not statistically significant) argue against drawing any conclusions at this time about the possible role of site-specific cancers. Although the self-report of cancer before baseline was not verified for most of these women, we have no reason to suspect nonrandom misclassification of cancer with respect to the outcome variable, and we would generally expect any misclassification to attenuate our results. We were unable to distinguish whether the cancer or its treatment was the relevant risk factor. Many cancers alter normal immunologic function, and their treatment is usually toxic to the immune system. Furthermore, many persons undergoing cancer treatment receive blood transfusions, which could confound this association, although these two variables appeared to be independent predictors of NHL risk in these data.
The use of nonestrogen steroids (most likely an immunosuppressive drug) was associated with increased risk in ageadjusted analyses but not in the multivariate model; however, in neither model was the point estimate statistically significant. Two case-control studies have reported a 70%-80% increase in the risk of NHL associated with the use of steroids (20, 21) . Our finding of no association between NHL and oral contraceptives or hormonereplacement therapy also corroborates data from two case-control studies (20, 21) , with the single exception of an association with the use of hormonereplacement therapy for longer than 13 months (odds ratio ‫ס‬ 1.58; 95% CI ‫ס‬ 1.09-2.29) (21). We also found no association with the use of thyroid medications; a single case-control study suggested an association with thyroid supplement use (21) .
These data suggest that adult-onset diabetes mellitus, previous blood transfusion, and previous cancer (or its treatment) are independent risk factors for NHL. The limitations of our study include the use of self-report data, the lack of data on family history of NHL, a low power to evaluate some associations, and the existence of limited or no data on the treatment of diabetes and earlier cancer. The strengths include the use of a prospective cohort study design, the use of a SEER cancer registry, and the existence of nearly complete follow-up of the cohort. While strong suppression of the immune system, such as that which occurs in primary immunodeficiency diseases, acquired immunodeficiency, and iatrogenic suppression, is associated with a large increase in risk of NHL, these latter conditions do not adequately explain the rapidly rising incidence of NHL, particularly among older persons. Common medical factors known to modulate the immune system, albeit at less intensity, appear to play a role in lymphomagenesis. The rising incidence rates in the United States of adult-onset diabetes [8% increase between 1979 and 1991 (37) ] and cancer [22% increase for all cancers between 1973 and 1991 (1)] and the increased use of blood transfusion [60% increase in the number of units transfused from 1971 through 1980 (38) ] has paralleled the rapid increase in the incidence of NHL (1) . Thus, these findings warrant further investigation, and they may suggest new insights into the pathogenesis and prevention of NHL.
